Christopher Loose
2019
In 2019, Christopher Loose earned a total compensation of $2.9M as Chief Scientific Officer at Korro Bio, a 401% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,000 |
|---|---|
| Option Awards | $2,278,077 |
| Salary | $379,167 |
| Other | $7,271 |
| Total | $2,894,515 |
Loose received $2.3M in option awards, accounting for 79% of the total pay in 2019.
Loose also received $230K in non-equity incentive plan, $379.2K in salary and $7.3K in other compensation.
Rankings
In 2019, Christopher Loose's compensation ranked 4,235th out of 13,971 executives tracked by ExecPay. In other words, Loose earned more than 69.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,235 out of 13,971 | 70th |
Division Manufacturing | 1,548 out of 5,695 | 73rd |
Major group Chemicals And Allied Products | 542 out of 2,194 | 75th |
Industry group Drugs | 454 out of 1,880 | 76th |
Industry Pharmaceutical Preparations | 348 out of 1,392 | 75th |
Source: SEC filing on April 29, 2020.
Loose's colleagues
We found two more compensation records of executives who worked with Christopher Loose at Korro Bio in 2019.